Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids

Peptides

Volumn 27, Issue 1, 2006, Pages 131-135

  Janecka, Anna ^a   Kruszynski, Rafal ^b   Fichna, Jakub ^a   Kosson, Piotr ^c   Janecki, Tomasz ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Receptor agonist; Binding studies; Brain homogenate; Constrained amino acids; Enzymatic hydrolysis

Indexed keywords

AMINO ACID; CARBOXYPEPTIDASE C; ENDOMORPHIN 2; MICROSOMAL AMINOPEPTIDASE; PEPTIDASE;

ARTICLE; ENZYME DEGRADATION; METHYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR BINDING; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION;

ALKYLATION; AMINO ACIDS; AMINOPEPTIDASES; ANIMALS; ANTIGENS, CD13; BRAIN; CARBOXYPEPTIDASE C; ENZYME STABILITY; KINETICS; LIGANDS; METHYLATION; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTORS, OPIOID, MU; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 30344483941     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.06.015     Document Type: Article

References (24)

1. G. Cardillo, L. Gentilucci, A.R. Qasem, F. Sgarzi, and S. Spampinato Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance J Med Chem 45 2002 2571 2578
2. G. Cardillo, L. Gentilucci, A. Tolomelli, M. Calienni, A.R. Qasem, and S. Spampinato Stability against enzymatic hydrolysis of endomorphin-1 analogues containing beta-proline Org Biomol Chem 1 2003 1498 1502
3. K.A. Carrigan, C.J. Nelson, and D.T. Lysle Endomorphin-1 induces antinociception without immunomodulatory effects in the rat Psychopharmacology (Berlin) 151 2000 299 305
4. K.J. Chang, E.T. Wei, A.J. Killian, and J.K. Chang Potent morphiceptin analogs: structure activity relationships and morphine-like activities J Pharmacol Exp Ther 227 1983 403 408
5. M.A. Czapla, D. Gozal, O.A. Alea, R.C. Beckerman, and J.E. Zadina Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine Am J Respir Crit Care Med 162 2000 994 999
6. J. Fichna, J.-C. Do-Rego, J. Costentin, N.N. Chung, P.W. Schiller, and P. Kosson Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs Biochem Biophys Res Commun 320 2004 531 536
7. H.W. Kosterlitz, J.A. Lord, S.J. Paterson, and A.A. Waterfield Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors Br J Pharmacol 68 1980 333 342
8. J.E. Mark, and M. Goodman Conformational aspects of polypeptides. Part XXIV: conformational energies of poly-N-methyl-l-alanine chains Biopolymers 5 1967 809 814
9. R. Mentlein Dipeptidyl-peptidase IV (CD26): role in the inactivation of regulatory peptides Regul Pept 85 1999 9 24
10. A. Misicka, A.W. Lipkowski, R. Horvath, P. Davis, T.H. Kramer, and H.I. Yamamura Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin Life Sci 51 1992 1025 1032
11. 2, and examination of their opioid receptor binding activities and solution conformation Biochem Biophys Res Commun 276 2000 7 11
12. M.G. Paterlini, S. Avitabile, B.G. Ostrowski, D.M. Ferguson, and P.S. Portoghese Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1 Biophys J 78 2000 590 599
13. A. Peter, G. Toth, C. Tomboly, G. Laus, and D. Tourwe Liquid chromatographic study of the enzymatic degradation of endomorphins, with identification by electrospray ionization mass spectrometry J Chromatogr A 846 1999 39 48
14. P.W. Schiller Development of receptor-selective opioid peptide analogs as pharmacological tools and as potential drugs A. Hertz Opioids vol. 1 1993 Springer Verlag Berlin 681
15. R. Schmidt, A. Kalman, N.N. Chung, C. Lemieux, C. Horvath, and P.W. Schiller Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence Int J Pept Protein Res 46 1995 47 55
16. R. Shane, S. Wilk, and R.J. Bodnar Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV Brain Res 815 1999 278 286
17. R.D. Soignier, A.L. Vaccarino, A.M. Brennan, A.J. Kastin, and J.E. Zadina Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice Life Sci 67 2000 907 912
18. M. Spetea, K. Monory, C. Tomboly, G. Toth, E. Tzavara, and S. Benyhe In vitro binding and signaling profile of the novel mu opioid receptor agonist endomorphin 2 in rat brain membranes Biochem Biophys Res Commun 250 1998 720 725
19. L.S. Stone, C.A. Fairbanks, T.M. Laughlin, H.O. Nguyen, T.M. Bushy, and M.W. Wessendorf Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2 Neuroreport 8 1997 3131 3135
20. C. Tomboly, A. Peter, and G. Toth In vitro quantitative study of the degradation of endomorphins Peptides 23 2002 1573 1580
21. A.M. Wilson, R.D. Soignier, J.E. Zadina, A.J. Kastin, W.L. Nores, and R.D. Olson Dissociation of analgesic and rewarding effects of endomorphin-1 in rats Peptides 21 2000 1871 1874
22. T. Yamazaki, S. Ro, and M. Goodman Topochemical analysis of morphiceptin and dermorphin bioactivities Biochem Biophys Res Commun 181 1991 664 670
23. T. Yamazaki, S. Ro, M. Goodman, N.N. Chung, and P.W. Schiller A topochemical approach to explain morphiceptin bioactivity J Med Chem 36 1993 708 719
24. J.E. Zadina, L. Hackler, L.J. Ge, and A.J. Kastin A potent and selective endogenous agonist for the mu-opiate receptor Nature 386 1997 499 502